Long-term outcomes after catheter-based renal artery denervation for resistant hypertension: final follow-up of the randomised SYMPLICITY HTN-3 Trial

Deepak L. Bhatt(Mount Sinai Hospital), William Downey, Eugene H. Chung(University of North Carolina at Chapel Hill), Murray Esler(Baker Heart and Diabetes Institute), George L. Bakris(Pennsylvania State System of Higher Education), Harold L. Dauerman(University of Vermont Medical Center), Keith Benzuly, James W. Choi(Baylor Jack and Jane Hamilton Heart and Vascular Hospital), Mark G. Davies(Ascension), Ralph B. D’Agostino(Wake Forest University), Vanessa DeBruin(Medtronic (United States)), Sheldon Chaffer, John M. Flack(Southern Illinois University School of Medicine), David A. Calhoun(University of Alabama at Birmingham), Krishna J. Rocha‐Singh(St. John's Hospital), Raymond R. Townsend(University of Pennsylvania), Anvar Babaev(Columbia University Irving Medical Center), Debbie L. Cohen(University of Pennsylvania), Ali E. Denktas(Michael E. DeBakey VA Medical Center), Mark A. Creager(Dartmouth–Hitchcock Medical Center), George Dangas(Mount Sinai Hospital), Muthiah Vaduganathan(Brigham and Women's Hospital), Eduardo de Marchena, Martin Fahy(Medtronic (United States)), David E. Kandzari(Piedmont Atlanta Hospital), Ziad Abbud, Tayo Addo, Herbert D. Aronow, Barry T. Katzen(Baptist Hospital of Miami), Laura Mauri(Brigham and Women's Hospital), Chandan Devireddy, David L. Brown(Baylor Scott & White Health), Paul N. Casale, Shukri David(Piedmont Atlanta Hospital), Sandeep Brar(Medtronic (United States)), David Anderson(The Alfred Hospital), Martin B. Leon(Columbia University Irving Medical Center), Manuela Negoita(Medtronic (United States)), Ray Townsend(California University of Pennsylvania), John F. Angle, Suzanne Oparil(University of Alabama at Birmingham), Somjot Brar(Kaiser Permanente), Sidney A. Cohen(University of Pennsylvania)
The Lancet
September 18, 2022
Cited by 181


Related Papers